Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Domino Foods, Inc. is the marketing and sales arm of ASR Group, the world's largest refined sugar company. In the life sciences and healthcare sectors, the company is a prominent supplier of high-purity, pharmaceutical-grade sucrose and specialty excipients through its Specialty Ingredients division. Their product line includes functional ingredients like Di-Pac and Sugartab, which are critical for the formulation of tablets, chewable medications, and liquid syrups. These products are manufactured in compliance with global pharmacopeia standards, including USP/NF, EP, and JP, ensuring the safety and stability of drug delivery systems. Beyond traditional pharmaceuticals, Domino Foods provides a variety of sweeteners and functional carbohydrates for the nutraceutical and clinical nutrition markets. The company’s focus on quality control and technical support makes it a key partner for pharmaceutical manufacturers worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Domino Foods.